Sagitta Biotech
Sagitta Biotech is a company developping an innovative viral vector to develop efficient vaccines, oncolytic viruses and gene therapy vectors. Our active virosome platform can deliver up to 17kb mRNA (6 genes), and elicit both humoral and cellular reponse. Sagitta is developping its own pipeline of innovative multivalent vaccines (currently in preclinical phases) and oncolytic viruses, and is open to partnering and co-development. In ancient Greece, Sagitta was regarded as the weapon that Hercules used to kill the eagle (Aquila) of Jove that perpetually gnawed Prometheus' liver.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Sagitta Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Sagitta Biotech
2 distinct titles indexed · top 2 shown.
- 1head of viral vector development
- 1é è
Sign up to unlock all 2 contacts at Sagitta Biotech
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Sagitta Biotech
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.